The new treatment regimen, recommended for patients aged three months to 16 years with non-severe drug-susceptible TB, is known as 2HRZE/2HR. It involves a two-month initial phase using four TB drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback